News
Lupin's Aurangabad unit completes product-specific pre-approval USFDA inspection
06-Sep-2025 | 10:36
With two observations
Lupin announced that the U.S. FDA has conducted a product-specific Pre-Approval Inspection (PAI) at the Company's Chhatrapati Sambhajinagar (Aurangabad) manufacturing facility from 01 September to 05 September 2025. The inspection closed with two observations.
Powered by Capital Market - Live News